Literature DB >> 28187809

Management of bacterial central nervous system infections.

M C Brouwer1, D van de Beek2.   

Abstract

Bacterial infections of the central nervous system present as a medical emergency, thus requiring rapid diagnosis and immediate treatment. The most prevalent bacterial infections seen in the intensive care unit can be summarized as acute bacterial meningitis, subdural empyema, intracerebral abscess, and ventriculitis, which all commonly involve the brain parenchyma. The infections can either be community-acquired or hospital-acquired, e.g., after neurosurgical intervention, as a complication of severe neurotrauma or related to indwelling cerebrospinal fluid drains. Community-acquired bacterial meningitis is most commonly caused by the pneumococcus (Streptococcus pneumoniae) and meningococcus (Neisseria meningtidis), and is often complicated by hearing loss, cerebrovascular complications, and seizures. Brain abscesses are frequently associated with contiguous or metastatic foci of infection such as otitis, sinusitis, pneumonia, or endocarditis which need to be detected and treated early during disease course. Despite optimal treatment, many patients are at risk for both major systemic and neurologic complications, leading to a substantial mortality and risk of major disability in survivors. Empiric treatment depends on regional antibiotic resistance patterns of common pathogens. For subdural empyema and brain abscesses, neurosurgical drainage of the infection is required alongside prolonged antibiotic treatment.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  antibiotic treatment; bacterial meningitis; brain abscess; dexamethasone; intracranial pressure; neurosurgery; subdural empyema

Mesh:

Year:  2017        PMID: 28187809     DOI: 10.1016/B978-0-444-63600-3.00019-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

1.  Risk Prediction of Central Nervous System Infection Secondary to Intraventricular Drainage in Patients with Intracerebral Hemorrhage: Development and Evaluation of a New Predictive Model Nomogram.

Authors:  Yanfeng Zhang; Qingkao Zeng; Yuquan Fang; Wei Wang; Yunjin Chen
Journal:  Ther Innov Regul Sci       Date:  2022-04-24       Impact factor: 1.337

2.  DNA repair protein APE1 is involved in host response during pneumococcal meningitis and its expression can be modulated by vitamin B6.

Authors:  Leonam G Coutinho; Ana Helena Sales de Oliveira; Matthias Witwer; Stephen L Leib; Lucymara F Agnez-Lima
Journal:  J Neuroinflammation       Date:  2017-12-12       Impact factor: 8.322

3.  Pediatric meningitis due to Neisseria meningitidis, Streptococcus pneumoniae and Group B Streptococcus in Tijuana, Mexico: active/prospective surveillance, 2005-2018.

Authors:  Enrique Chacon-Cruz; Christopher Roberts; Rosa Maria Rivas-Landeros; Erika Zoe Lopatynsky-Reyes; Lucila Alejandra Almada-Salazar; Jorge Arturo Alvelais-Palacios
Journal:  Ther Adv Infect Dis       Date:  2019-03-11

4.  Multiple brain abscesses treated by extraction of the maxillary molars with chronic apical lesion to remove the source of infection.

Authors:  Ki-Hyun Jung; Seong-Su Ro; Seong-Won Lee; Jae-Yoon Jeon; Chang-Joo Park; Kyung-Gyun Hwang
Journal:  Maxillofac Plast Reconstr Surg       Date:  2019-07-03

Review 5.  Diagnosis of Streptococcus suis Meningoencephalitis with metagenomic next-generation sequencing of the cerebrospinal fluid: a case report with literature review.

Authors:  Xiaobo Zhang; Zhaoping Wu; Kai Wang
Journal:  BMC Infect Dis       Date:  2020-11-25       Impact factor: 3.090

6.  Use of the FilmArray® Meningitis/Encephalitis panel to detect pathogenic microorganisms in cerebrospinal fluid specimens: a single-center retrospective study.

Authors:  Makoto Hara; Masaki Ishihara; Hideto Nakajima
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

Review 7.  Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review.

Authors:  Ibrahim Alnaami; Zubaidah Alahmari
Journal:  Trop Med Infect Dis       Date:  2022-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.